Table 1.
Patients with Germline BAP1 Alterations (Total, N=215) | Median Age of Onset (years) | |||
---|---|---|---|---|
Tumor Type | No. of tumors of specific class, N | % of patients with tumor of specific class | Tumors with Germline BAP1 Mutations | Sporadic Tumors |
Uveal melanoma | 60 | 28% | 59 | 62 |
Malignant mesothelioma | 48 | 22% | 46 | 74 |
Cutaneous melanoma | 38 | 18% | 43 | 61 |
Renal cell carcinoma | 20 | 9% | 51 | 64 |
Basal cell carcinoma | 14 | 7% | 41 | 75 |
BAP1-inactivated melanocytic tumor (BIMT)* | 40 | 75% | 31 | 24 |
Of the total 215 patients with BAP1-TPDS, 53 underwent the necessary total body skin examination to diagnose BIMT; of these, 40 patients (75%) had a positive diagnosis for one or more BIMTs.